20 May 2020 07:00
20 May 2020
Redx Pharma plc
("Redx" or "the Company")
Change of Adviser
The Company announces that SPARK Advisory Partners Limited has been appointed as the Company's nominated adviser with immediate effect.
For further information, please contact: |
|
|
|
Redx Pharma Plc | T: +44 1625 469 918 |
Iain Ross, Chairman Lisa Anson, Chief Executive |
|
|
|
SPARK Advisory Partners Limited (Nominated Adviser) | T: +44 203 368 3550 |
Matt Davis/Andrew Emmott |
|
|
|
WG Partners LLP (Broker) | T: +44 20 3705 9330 |
Claes Spång/Chris Lee/David Wilson |
|
|
|
FTI Consulting | T: +44 20 3727 1000 |
Simon Conway/Ciara Martin |
|
|
|
About Redx Pharma Plc
Redx is a UK based biotechnology company whose shares are traded on AIM (AIM:REDX). Redx's vision is to become a leading biotech focused on the development of novel precision medicines that have the potential to transform treatment in oncology and fibrotic diseases.
If you would like to sign up to regular alerts from Redx Pharma, please follow this link https://www.redxpharma.com/investors/email-alerts/
REDX.L (REDX)